JitterinessAnxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline
Joint Authors
Nakamura, Toshinori
Sugiyama, Nobuhiro
Sasayama, Daimei
Hagiwara, Tetsuya
Washizuka, Shinsuke
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-08-22
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Here, we report our experience with patients in whom jitteriness/anxiety syndrome developed immediately following the start of oral sertraline administration.
Administration was discontinued in these patients on day 2, and the jitteriness/anxiety syndrome improved the following day.
Jitteriness/anxiety syndrome may develop immediately following oral administration of even low doses of sertraline, and improvement can be expected if sertraline is promptly discontinued.
American Psychological Association (APA)
Nakamura, Toshinori& Sugiyama, Nobuhiro& Sasayama, Daimei& Hagiwara, Tetsuya& Washizuka, Shinsuke. 2017. JitterinessAnxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline. Case Reports in Psychiatry،Vol. 2017, no. 2017, pp.1-2.
https://search.emarefa.net/detail/BIM-1149554
Modern Language Association (MLA)
Nakamura, Toshinori…[et al.]. JitterinessAnxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline. Case Reports in Psychiatry No. 2017 (2017), pp.1-2.
https://search.emarefa.net/detail/BIM-1149554
American Medical Association (AMA)
Nakamura, Toshinori& Sugiyama, Nobuhiro& Sasayama, Daimei& Hagiwara, Tetsuya& Washizuka, Shinsuke. JitterinessAnxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline. Case Reports in Psychiatry. 2017. Vol. 2017, no. 2017, pp.1-2.
https://search.emarefa.net/detail/BIM-1149554
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1149554